Question 1

Does BlackRock own QNCX stock?

Accepted Answer

As of its Q1 2026 13F, BlackRock held 473,259 shares of QNCX (Quince Therapeutics), worth $47,989.

Question 2

How many shares of QNCX does BlackRock own?

Accepted Answer

As of its Q1 2026 13F, BlackRock held 473,259 shares of QNCX (Quince Therapeutics).

Question 3

What is BlackRock's QNCX position worth?

Accepted Answer

As of its Q1 2026 13F, BlackRock's QNCX position was worth $47,989.

Question 4

When did BlackRock first buy QNCX?

Accepted Answer

BlackRock already held QNCX in its Q3 2024 13F, the earliest on record, and listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$18.19	0
2026-Q1	Increased	473,259	+0.3%	$47,989	0.0%	$20.20	14
2025-Q4	Increased	471,989	+36.6%	$1.6M	0.0%	$670.00	23
2025-Q3	Increased	345,461	+2.9%	$563,101	0.0%	$326.00	17
2025-Q2	Decreased	335,738	-2.8%	$553,968	0.0%	$330.00	0
2025-Q1	Decreased	345,448	-22.9%	$459,446	0.0%	$266.00	0
2024-Q4	Increased	447,733	+24.9%	$837,261	0.0%	$374.00	21
2024-Q3	First report	358,358	—	$278,159	0.0%	$155.20	0